JOHN L. HIGGINS - 08 Jul 2024 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Director
Signature
/s/ Andrew Nick as Attorney-in-Fact for John L. Higgins pursuant to Power of Attorney previously filed
Issuer symbol
TECH
Transactions as of
08 Jul 2024
Transactions value $
$137,700
Form type
4
Filing time
10 Jul 2024, 16:35:10 UTC
Previous filing
21 Jun 2024
Next filing
16 Sep 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TECH Common Stock Options Exercise $138K +6K +16.39% $22.95 42.6K 08 Jul 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Stock Options (Right to Buy) Options Exercise $0 -6K -50% $0.00 6K 08 Jul 2024 Common Stock 6K $22.95 Direct
holding TECH Stock Options (Right to Buy) 17K 08 Jul 2024 Common Stock 17K $21.84 Direct
holding TECH Stock Options (Right to Buy) 15.9K 08 Jul 2024 Common Stock 15.9K $25.30 Direct
holding TECH Stock Options (Right to Buy) 12.5K 08 Jul 2024 Common Stock 12.5K $31.26 Direct
holding TECH Stock Options (Right to Buy) 7.59K 08 Jul 2024 Common Stock 7.59K $44.96 Direct
holding TECH Stock Options (Right to Buy) 8.04K 08 Jul 2024 Common Stock 8.04K $50.41 Direct
holding TECH Stock Options (Right to Buy) 6.03K 08 Jul 2024 Common Stock 6.03K $63.92 Direct
holding TECH Stock Options (Right to Buy) 2.53K 08 Jul 2024 Common Stock 2.53K $128.81 Direct
holding TECH Stock Options (Right to Buy) 3.46K 08 Jul 2024 Common Stock 3.46K $73.94 Direct
holding TECH Stock Options (Right to Buy) 3.94K 08 Jul 2024 Common Stock 3.94K $61.51 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests on the earlier of the one year anniversary of the grant date (10/26/2023) or the date of Bio-Techne's 2024 annual meeting of shareholders.